Bfsg LLC Acquires Shares of 1,958 The Chemours Company (NYSE:CC)

Bfsg LLC acquired a new stake in The Chemours Company (NYSE:CCFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 1,958 shares of the specialty chemicals company’s stock, valued at approximately $62,000.

A number of other institutional investors have also recently bought and sold shares of CC. Deutsche Bank AG boosted its holdings in Chemours by 4,407.9% in the 3rd quarter. Deutsche Bank AG now owns 1,759,419 shares of the specialty chemicals company’s stock valued at $49,352,000 after purchasing an additional 1,720,389 shares during the period. Bank of New York Mellon Corp increased its position in Chemours by 11.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 6,196,063 shares of the specialty chemicals company’s stock worth $173,800,000 after purchasing an additional 612,071 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in Chemours by 10.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,160,740 shares of the specialty chemicals company’s stock worth $88,659,000 after purchasing an additional 286,076 shares in the last quarter. Tudor Investment Corp Et Al increased its position in Chemours by 10,530.9% during the 3rd quarter. Tudor Investment Corp Et Al now owns 219,049 shares of the specialty chemicals company’s stock worth $6,144,000 after purchasing an additional 221,149 shares in the last quarter. Finally, Assenagon Asset Management S.A. acquired a new position in Chemours during the 4th quarter worth approximately $4,711,000. Institutional investors own 76.26% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on CC shares. UBS Group upped their price target on shares of Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research report on Tuesday, April 2nd. Barclays reduced their price objective on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Finally, BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and upped their price objective for the company from $19.00 to $34.00 in a research note on Tuesday, April 9th. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $30.89.

Get Our Latest Report on Chemours

Chemours Stock Down 0.2 %

Shares of NYSE CC opened at $27.03 on Friday. The Chemours Company has a 12-month low of $15.10 and a 12-month high of $39.05. The company’s fifty day simple moving average is $26.73 and its 200 day simple moving average is $27.80. The company has a debt-to-equity ratio of 5.40, a current ratio of 1.54 and a quick ratio of 1.00.

Chemours (NYSE:CCGet Free Report) last released its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. On average, equities analysts predict that The Chemours Company will post 2.23 EPS for the current fiscal year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.70%. The ex-dividend date was Friday, February 23rd. Chemours’s dividend payout ratio (DPR) is -64.52%.

About Chemours

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Recommended Stories

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.